(Q41576606)

English

Prognostic Significance of Tumor-Infiltrating Lymphocytes and the Tertiary Lymphoid Structures in HER2-Positive Breast Cancer Treated With Adjuvant Trastuzumab

scientific article published on August 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

4 October 2017

Prognostic Significance of Tumor-Infiltrating Lymphocytes and the Tertiary Lymphoid Structures in HER2-Positive Breast Cancer Treated With Adjuvant Trastuzumab (English)

1 reference

Europe PubMed Central

4 October 2017

tertiary lymphoid structure

1 reference

based on heuristic

inferred from title

author name string

Hee Jin Lee

1

1 reference

Europe PubMed Central

4 October 2017

Joo Young Kim

2

1 reference

Europe PubMed Central

4 October 2017

In Ah Park

3

1 reference

Europe PubMed Central

4 October 2017

In Hye Song

4

1 reference

Europe PubMed Central

4 October 2017

Jong Han Yu

5

1 reference

Europe PubMed Central

4 October 2017

Jin-Hee Ahn

6

1 reference

Europe PubMed Central

4 October 2017

Gyungyub Gong

7

1 reference

Europe PubMed Central

4 October 2017

language of work or name

1 reference

American Journal of Clinical Pathology

publication date

1 August 2015

1 reference

Europe PubMed Central

4 October 2017

American Journal of Clinical Pathology

1 reference

Europe PubMed Central

4 October 2017

144

1 reference

Europe PubMed Central

4 October 2017

2

1 reference

Europe PubMed Central

4 October 2017

278-288

1 reference

Europe PubMed Central

4 October 2017

Two histopathologically different diseases: hormone receptor-positive and hormone receptor-negative tumors in HER2-positive breast cancer.

1 reference

https://api.crossref.org/works/10.1309%2FAJCPIXUYDVZ0RZ3G

21 January 2018

Tumor-associated lymphocytes as an independent predictor of response to neoadjuvant chemotherapy in breast cancer.

1 reference

https://api.crossref.org/works/10.1309%2FAJCPIXUYDVZ0RZ3G

21 January 2018

Impact of hormone receptor status on patterns of recurrence and clinical outcomes among patients with human epidermal growth factor-2-positive breast cancer in the National Comprehensive Cancer Network: a prospective cohort study

1 reference

https://api.crossref.org/works/10.1309%2FAJCPIXUYDVZ0RZ3G

21 January 2018

Vascular characterisation of triple negative breast carcinomas using dynamic MRI.

1 reference

https://api.crossref.org/works/10.1309%2FAJCPIXUYDVZ0RZ3G

21 January 2018

Prognostic and predictive value of tumor-infiltrating lymphocytes in a phase III randomized adjuvant breast cancer trial in node-positive breast cancer comparing the addition of docetaxel to doxorubicin with doxorubicin-based chemotherapy: BIG 02-98

1 reference

https://api.crossref.org/works/10.1309%2FAJCPIXUYDVZ0RZ3G

21 January 2018

Tumor-associated lymphocytes predict response to neoadjuvant chemotherapy in breast cancer patients

1 reference

https://api.crossref.org/works/10.1309%2FAJCPIXUYDVZ0RZ3G

21 January 2018

Tumour-infiltrating CD8+ lymphocytes as an independent predictive factor for pathological complete response to primary systemic therapy in breast cancer

1 reference

https://api.crossref.org/works/10.1309%2FAJCPIXUYDVZ0RZ3G

21 January 2018

The relationship between lymphocyte subsets and clinico-pathological determinants of survival in patients with primary operable invasive ductal breast cancer

1 reference

https://api.crossref.org/works/10.1309%2FAJCPIXUYDVZ0RZ3G

21 January 2018

The relationship between components of tumour inflammatory cell infiltrate and clinicopathological factors and survival in patients with primary operable invasive ductal breast cancer

1 reference

https://api.crossref.org/works/10.1309%2FAJCPIXUYDVZ0RZ3G

21 January 2018

Increased lymphocytic infiltration in breast cancer correlated with molecular subtypes and HER2 gene amplification

1 reference

https://api.crossref.org/works/10.1309%2FAJCPIXUYDVZ0RZ3G

21 January 2018

Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer

1 reference

https://api.crossref.org/works/10.1309%2FAJCPIXUYDVZ0RZ3G

21 January 2018

Concomitant targeting of tumor cells and induction of T-cell response synergizes to effectively inhibit trastuzumab-resistant breast cancer

1 reference

https://api.crossref.org/works/10.1309%2FAJCPIXUYDVZ0RZ3G

21 January 2018

Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets

1 reference

https://api.crossref.org/works/10.1309%2FAJCPIXUYDVZ0RZ3G

21 January 2018

Superior in vivo efficacy of afucosylated trastuzumab in the treatment of HER2-amplified breast cancer

1 reference

https://api.crossref.org/works/10.1309%2FAJCPIXUYDVZ0RZ3G

21 January 2018

Immunoglobulin G fragment C receptor polymorphisms and clinical efficacy of trastuzumab-based therapy in patients with HER-2/neu-positive metastatic breast cancer.

1 reference

https://api.crossref.org/works/10.1309%2FAJCPIXUYDVZ0RZ3G

21 January 2018

The therapeutic effect of anti-HER2/neu antibody depends on both innate and adaptive immunity

1 reference

https://api.crossref.org/works/10.1309%2FAJCPIXUYDVZ0RZ3G

21 January 2018

Anti-ErbB-2 mAb therapy requires type I and II interferons and synergizes with anti-PD-1 or anti-CD137 mAb therapy

1 reference

https://api.crossref.org/works/10.1309%2FAJCPIXUYDVZ0RZ3G

21 January 2018

Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial

1 reference

https://api.crossref.org/works/10.1309%2FAJCPIXUYDVZ0RZ3G

21 January 2018

Human solid tumors contain high endothelial venules: association with T- and B-lymphocyte infiltration and favorable prognosis in breast cancer.

1 reference

https://api.crossref.org/works/10.1309%2FAJCPIXUYDVZ0RZ3G

21 January 2018

Characteristics of tertiary lymphoid structures in primary cancers

1 reference

https://api.crossref.org/works/10.1309%2FAJCPIXUYDVZ0RZ3G

21 January 2018

Ligands for L-selectin: homing, inflammation, and beyond

1 reference

https://api.crossref.org/works/10.1309%2FAJCPIXUYDVZ0RZ3G

21 January 2018

Neo-antigens predicted by tumor genome meta-analysis correlate with increased patient survival

1 reference

https://api.crossref.org/works/10.1309%2FAJCPIXUYDVZ0RZ3G

21 January 2018

American society of clinical oncology/college of american pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer.

1 reference

https://api.crossref.org/works/10.1309%2FAJCPIXUYDVZ0RZ3G

21 January 2018

Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer

1 reference

https://api.crossref.org/works/10.1309%2FAJCPIXUYDVZ0RZ3G

21 January 2018

Inflammation and prognosis in colorectal cancer.

1 reference

https://api.crossref.org/works/10.1309%2FAJCPIXUYDVZ0RZ3G

21 January 2018

The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014.

1 reference

https://api.crossref.org/works/10.1309%2FAJCPIXUYDVZ0RZ3G

21 January 2018

A new pathological system for grading DCIS with improved prediction of local recurrence: results from the UKCCCR/ANZ DCIS trial

1 reference

https://api.crossref.org/works/10.1309%2FAJCPIXUYDVZ0RZ3G

21 January 2018

CD4⁺ follicular helper T cell infiltration predicts breast cancer survival

1 reference

https://api.crossref.org/works/10.1309%2FAJCPIXUYDVZ0RZ3G

21 January 2018

High endothelial venule blood vessels for tumor-infiltrating lymphocytes are associated with lymphotoxin β-producing dendritic cells in human breast cancer.

1 reference

https://api.crossref.org/works/10.1309%2FAJCPIXUYDVZ0RZ3G

21 January 2018

Histopathological characterization of ductal carcinoma in situ (DCIS) of the breast according to HER2 amplification status and molecular subtype.

1 reference

https://api.crossref.org/works/10.1309%2FAJCPIXUYDVZ0RZ3G

21 January 2018

Occurrence of tertiary lymphoid tissue is associated with T-cell infiltration and predicts better prognosis in early-stage colorectal cancers

1 reference

https://api.crossref.org/works/10.1309%2FAJCPIXUYDVZ0RZ3G

21 January 2018

Tumor-infiltrating lymphocytes, breast cancer subtypes and therapeutic efficacy

1 reference

https://api.crossref.org/works/10.1309%2FAJCPIXUYDVZ0RZ3G

21 January 2018

Expression of MHC Class I on breast cancer cells correlates inversely with HER2 expression

1 reference

https://api.crossref.org/works/10.1309%2FAJCPIXUYDVZ0RZ3G

21 January 2018

Identifiers

10.1309/AJCPIXUYDVZ0RZ3G

1 reference

Europe PubMed Central

4 October 2017

release_hp3lqr4fwzfsppgbigd7goaany

1 reference

https://api.fatcat.wiki/v0/release/hp3lqr4fwzfsppgbigd7goaany

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

4 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41576606&oldid=1924615035"